Friday, April 19, 2024
4/19/2024
PROJECT SUMMARY/ABSTRACT Adoptive cell transfer (ACT) immunotherapies repurpose T cells from patients to specifically eliminate tumor cells by engineering them to express antigen-specific T cell receptors (TCRs) and chimeric antigen receptors (CARs). Currently, engineered T cell manufacturing is patient-specific and the timeline and cost of manufacture which may limit access to these new therapies. Some patients have a prognosis for survival that does not end beyond the inherent time required for cell manufacturing (on average 22 days for a current FDA-approved CAR- T product), and clinical responses are uneven and are related, at least partly, to the functional variability of the T cell composition of each product. This proposal seeks to remove these barriers by engineering human pluripotent stem cells (hPSCs) to generate non-alloreactive, antigen-specific mature, naïve T cells using the Artificial Thymic Organoid (ATO) system, a novel in vitro method for efficiently and reproducibly producing mature, naïve T cells from stem cell sources. CRISPR/Cas9 gene-editing will be used in hPSCs to generate insertion deletion mutations (INDELs) to knockout the beta-2-microglublin (B2M) gene, the critical subunit of all Class I MHC heterodimers, to prevent Class I MHC-mediated allo-rejection of T cells. To prevent the rearrangement of endogenous, and potentially allo-reactive TCRs, a multiplex CRISPR/Cas9 strategy will be used in hPSCs to completely excise the locus containing the recombination-activating-genes RAG1 and RAG2 in hPSCs. Together, these experiments will develop a platform for generating stem cell-derived, non-alloreactive mature naïve T cells that could ultimately be applied toward an “off-the-shelf” approach to T cell immunotherapy.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
